Home » Topics » Regulatory » Patents

Patents
RSS

ViroPharma develops agents for HCV infection

Dec. 16, 1997

5-HT receptor (ant)agonists from Pfizer

Dec. 16, 1997

Natural anti-HIV agent disclosed by Hoechst

Dec. 16, 1997

Searle describes selective alphav/beta3 integrin antagonists

Dec. 16, 1997

Agents for HCV infection from ViroPharma

Dec. 11, 1997

3-Dimensional Pharmaceuticals discloses new serine protease inhibitors

Dec. 11, 1997

Protein farnesyltransferase inhibitors focus of research at Merck & Co.

Dec. 11, 1997

CRF antagonists from DuPont Merck for anxiety, depression and related disorders

Dec. 9, 1997

Alteon prepares new AGE inhibitors

Dec. 9, 1997

Byk Gulden presents new PDE IV inhibitors

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...